FR
Frontier Med
FRON·NASDAQS San Francisco CAFounded 201740 employees
Micro CapbiotechPublicOncology
Platform: FMC-376 MEKi
Market Cap
$0.15B
All Drugs
2
Clinical Trials
4
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (FRON)
Loading FRON stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Olpacagene | FRO-4682 | NDA/BLA | 2 | CD20 | MSMyelofibrosis | ||
| Gozederotide | FRO-9558 | NDA/BLA | 2 | WEE1 | LGSNarcolepsy |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)